HedgeChatter

  • Home /
  • Tag Archives

ARRY

Array BioPharma To Present At The Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare Conference

[PR Newswire] – BOULDER, Colo., May 12, 2014 /PRNewswire/ — Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Bank of America Merrill Lynch Healthcare … moreView todays social media effects on ARRYView the latest stocks trending across Twitter. Click to view dashboardSee who Array is hiring next, click here to […]

May 12, 2014 Bystocknews , Comments Off on Array BioPharma To Present At The Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare Conference read more

Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014

[PR Newswire] – BOULDER, Colo., April 23, 2014 /PRNewswire/ — Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the third quarter of fiscal 2014 and hold a conference call to discuss those results … moreView todays social media effects on ARRYView the latest stocks trending across Twitter. Click to view dashboardSee who Array is hiring next, click here […]

April 23, 2014 Bystocknews , Comments Off on Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014 read more

Array BioPharma Provides Clinical Update On ARRY-502 For Asthma At Scientific Meeting

[at noodls] – BOULDER, Colo., March 3, 2014 /PRNewswire/ — Array BioPharma Inc. (NASDAQ: ARRY) reported full results from a randomized Phase 2 trial of ARRY-502 in patients with mild to moderate Th2-Driven Asthma at … moreView todays social media effects on ARRYView the latest stocks trending across Twitter. Click to view dashboardSee who Array is hiring next, click here […]

March 3, 2014 Bystocknews , Comments Off on Array BioPharma Provides Clinical Update On ARRY-502 For Asthma At Scientific Meeting read more

8:02 am Array BioPharma provides clinical update on ARRY-502 for asthma at scientific meeting; ARRY-502 met the primary endpoint in the trial, secondary efficacy endpoints also achieved statistical significance

moreView todays social media effects on ARRYView the latest stocks trending across Twitter. Click to view dashboardSee who Array is hiring next, click here to view […]

March 3, 2014 Bystocknews , Comments Off on 8:02 am Array BioPharma provides clinical update on ARRY-502 for asthma at scientific meeting; ARRY-502 met the primary endpoint in the trial, secondary efficacy endpoints also achieved statistical significance read more

Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ONT-380 in Combination with TDM-1 in Patients with Metastatic HER2+ Breast Cancer

[at noodls] – SEATTLE, WA and BOULDER, CO, Feb. 20, 2014 /PRNewswire/ – Oncothyreon Inc. (NASDAQ: ONTY) and Array BioPharma Inc. (NASDAQ: ARRY) today announced the initiation of a Phase 1b trial of ONT-380 (ARRY-380) … moreView todays social media effects on ARRYView the latest stocks trending across Twitter. Click to view dashboardSee who Array is hiring next, click here […]

February 20, 2014 Bystocknews , Comments Off on Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ONT-380 in Combination with TDM-1 in Patients with Metastatic HER2+ Breast Cancer read more

Array BioPharma To Present At The RBC Capital Markets Global Healthcare And Cowen Annual Healthcare Conferences

[PR Newswire] – BOULDER, Colo., Feb. 18, 2014 /PRNewswire/ — Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the RBC Capital Markets Global Healthcare … moreView todays social media effects on ARRYView the latest stocks trending across Twitter. Click to view dashboardSee who Array is hiring next, click here to view […]

February 18, 2014 Bystocknews , Comments Off on Array BioPharma To Present At The RBC Capital Markets Global Healthcare And Cowen Annual Healthcare Conferences read more